Holders · period archive

OHRPEUR · Neubase Therapeutics Inc.

Q2 2023 13F holders among managers we track latest ownership dossier

Ticker: OHRPEUR
Type: Equity
Class: COM NEW
Total reported value ($000, long equity)

Manager	Report date	Value	Shares